美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	214628	001	NDA	NOREPINEPHRINE BITARTRATE	SOLUTION;INTRAVENOUS	EQ 4MG BASE/250 ML (EQ 16MCG BASE/ML)	Yes	Yes	2022/10/06	2022/10/06	LONG GROVE PHARMS	Prescription
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	214628	002	NDA	NOREPINEPHRINE BITARTRATE	SOLUTION;INTRAVENOUS	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	Yes	Yes	2022/10/06	2022/10/06	LONG GROVE PHARMS	Prescription
NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE	214628	003	NDA	NOREPINEPHRINE BITARTRATE	SOLUTION;INTRAVENOUS	EQ 16MG BASE/250ML (EQ 64MCG BASE/ML)	Yes	Yes	2022/10/06	2022/10/06	LONG GROVE PHARMS	Prescription
NOREPINEPHRINE BITARTRATE	217575	001	ANDA	NOREPINEPHRINE BITARTRATE	INJECTABLE;INJECTION	EQ 1MG BASE/ML	No	No	2023/09/15	2023/09/15	CAPLIN	Prescription
NOREPINEPHRINE BITARTRATE	218758	001	ANDA	NOREPINEPHRINE BITARTRATE	INJECTABLE;INJECTION	EQ 1MG BASE/ML	No	No	2024/05/13	2024/05/13	RISING	Prescription
NOREPINEPHRINE BITARTRATE	219163	001	ANDA	NOREPINEPHRINE BITARTRATE	INJECTABLE;INJECTION	EQ 1MG BASE/ML	No	No	2025/01/31	2025/01/31	ASPIRO	Prescription
NOREPINEPHRINE BITARTRATE	219443	001	ANDA	NOREPINEPHRINE BITARTRATE	INJECTABLE;INJECTION	EQ 1MG BASE/ML	No	No	2025/03/21	2025/03/21	BIOCON PHARMA	Prescription
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE	219692	001	ANDA	NOREPINEPHRINE BITARTRATE	SOLUTION;INTRAVENOUS	EQ 4MG BASE/250ML (EQ 16MCG BASE/ML)	No	No	2025/08/11	2025/08/11	SAGENT	Prescription
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE	219692	002	ANDA	NOREPINEPHRINE BITARTRATE	SOLUTION;INTRAVENOUS	EQ 8MG BASE/250ML (EQ 32MCG BASE/ML)	No	No	2025/08/11	2025/08/11	SAGENT	Prescription
NOREPINEPHRINE BITARTRATE	219924	001	ANDA	NOREPINEPHRINE BITARTRATE	INJECTABLE;INJECTION	EQ 1MG BASE/ML	No	No	2025/11/25	--	ANTHEA PHARMA	Prescription